Clinical trials for Atrial fibrillation investigate a range of treatment strategies and patient populations.

13 total trials for this combination

Showing top 10 of 13 trials

Trials

NCT ID	Title	Status	Phase
NCT00262600	Randomized Evaluation of Long Term Anticoagulant Therapy (RE-LY) With Dabigatran Etexilate	COMPLETED	PHASE3
NCT00403767	An Efficacy and Safety Study of Rivaroxaban With Warfarin for the Prevention of Stroke and Non-Central Nervous System Systemic Embolism in Patients With Non-Valvular Atrial Fibrillation	COMPLETED	PHASE3
NCT01701817	Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II)	COMPLETED	—
NCT00496769	A Phase III Study of Apixaban in Patients With Atrial Fibrillation	COMPLETED	PHASE3
NCT00402246	CONNECT Study - Clinical Evaluation Of Remote NotificatioN to rEduCe Time to Clinical Decision	COMPLETED	NA
NCT05643573	A Study to Learn How Well the Study Treatment Asundexian Works and How Safe it is Compared to Apixaban to Prevent Stroke or Systemic Embolism in People With Irregular and Often Rapid Heartbeat (Atrial Fibrillation), and at Risk for Stroke	TERMINATED	PHASE3
NCT01674647	Explore the Efficacy and Safety of Once-daily Oral Rivaroxaban for the Prevention of Cardiovascular Events in Subjects With Nonvalvular Atrial Fibrillation Scheduled for Cardioversion	COMPLETED	PHASE3
NCT00580216	Evaluation of Weekly Idrabiotaparinux Sodium Versus Oral Adjusted-dose Warfarin to Prevent Stroke and Systemic Thromboembolic Events in Patients With Atrial Fibrillation	TERMINATED	PHASE3
NCT00781391	Global Study to Assess the Safety and Effectiveness of Edoxaban (DU-176b) vs Standard Practice of Dosing With Warfarin in Patients With Atrial Fibrillation	COMPLETED	PHASE3
NCT00412984	Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation	COMPLETED	PHASE3

Related Pages

All Atrial fibrillation trials All trials in Santa Rosa, United States